Ruggie Capital Group’s Pfizer PFE Stock Holding History

Ruggie Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$19K	Buy	538 +6	+1%	+$210	0.98%	33
2020 Q2	$16K	Buy	532 +5	+0.9%	+$170	1.32%	26
2020 Q1	$16K	Buy	+527	New	+$18K	1.67%	22
2019 Q1	–	Sell	-1,051	Closed	-$44K	–	370
2018 Q4	$44K	Buy	+1,051	New	+$43.6K	0.02%	181
2015 Q4	–	Sell	-488	Closed	-$16K	–	127
2015 Q3	$16K	Sell	488 -723	-60%	-$23.2K	0.02%	119
2015 Q2	$39K	Buy	1,211 +723	+148%	+$23.6K	0.03%	100
2015 Q1	$16K	Sell	488 -608	-55%	-$19.3K	0.02%	121
2014 Q4	$32K	Buy	+1,096	New	+$31.4K	0.03%	99

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ruggie Capital Group's PFE Position: Q3 2020 in Review

Ruggie Capital Group increased its Pfizer (PFE) stake by 1.1% in Q3 2020, buying an estimated $210 and bringing the position to 538 shares worth $19K. The position accounts for 0.98% of the portfolio, ranked #33.

Ruggie Capital Group first reported a position in PFE in Q4 2014 and has held it in 8 quarters since. The position peaked at $44K in Q4 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Ruggie Capital Group held 538 shares of Pfizer worth $19K as of Q3 2020.
Ruggie Capital Group bought 6 Pfizer shares in Q3 2020, an estimated $210.
Pfizer made up 0.98% of Ruggie Capital Group's portfolio in Q3 2020, its #33 holding.
Ruggie Capital Group first reported a position in Pfizer in Q4 2014 and has held it in 8 quarters since.
Ruggie Capital Group's Pfizer position peaked at $44K in Q4 2018.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Ruggie Capital Group's 13F filing for Q3 2020, filed 29 Oct 2020.